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Background: Metabolic syndrome (MS) and hepatitis B (HBV) infection are two major public health problems in
China. There are few studies about their association, and the results of these studies are contradictory. We conducted a
retrospective cohort study to assess the association between MS and HBV in a Shanghai community-based cohort.
Methods: Nine hundred seventy-six Shanghai residents were recruited from the Putuo community. 480 HBV infections
were in exposed group and 496 non-infections in unexposed group. All metabolic-related parameters and hepatitis B
serology were tested with routine biochemical or immunological methods. “Exposed” was defined by HBV infection
represented by hepatitis B surface antigen (HBsAg) and without anti-virus treatment. “Unexposed” were subjects who
didn’t infect with HBV (Represented by HBsAg) and no MS when they entered the cohort. MS was defined based on
the updated National Cholesterol Education Program Adult Treatment Panel III criteria. The Cox proportional hazards
model was used to estimate the hazard ratios (HR) and related 95% confidence intervals (95% CI) for the association
between HBV infection and MS over a 20-year follow-up period.
Results: Of 976 subjects recruited, 480 had latent HBV infection (exposed subjects). After adjusting for age, the crude
HR was 2.46 (95% CI: 1.77, 3.41). After adjusting for potential risk factors of MS (age, gender, smoking, passive smoking,
alcohol consumption, physical activity, and diet), the HR was 2.27 (95% CI: 1.52, 3.38).
Conclusions: This 20-year follow-up retrospective cohort study in Shanghai showed a positive association between
HBV infection and MS.Background
Metabolic syndrome (MS) is a complicated metabolic
disorder comprising obesity, hypertension, diabetes, and
dyslipidemia. MS has been verified as a risk factor for
cardiovascular disease, type 2 diabetes, and renal disease
[1-5], and increases mortality from all causes [6]. MS is
recognized as a major public health problem world-
wide [7,8].
China is endemic for hepatitis B virus (HBV) infection,
with a prevalence of nearly 10% [9] in those subjects over
40 in 2006. This age cohort did not receive regular hepa-
titis B vaccination.
Evidence suggests that hepatitis C virus (HCV) infection
has an impact on lipid and glucose metabolism [10-14]. A
community-based study in Taiwan found HCV infection* Correspondence: jmy@fudan.edu.cn
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unless otherwise stated.to be associated with MS (odds ratio 6.4; 95% CI: 1.82 to
22.84) [15]. Similarly to HCV, it is thought that HBV
might lead to chronic liver damage by dyslipidemia. A
study by Su et al. [16] reported an association between
asymptomatic chronic HBV infection and lower serum
levels of total cholesterol (TC) and high-density lipopro-
tein cholesterol (HDL-C). This evidence suggests that
HBV might affect metabolic profiles and subsequent
development of MS. However, studies of the correlation
between HBV infection and MS yield contradictory results.
Three studies reported a positive association between HBV
infection and MS [17-19], two found an inverse association
[20,21], and one found no association [22]. The contradic-
tions may be due to small sample size [23] and limitation of
subjects to hospital patients [24]. Another study suggested
that MS might cause worsening of cirrhosis in chronic
HBV patients [25], suggesting a relationship between MS
and HBV infection. It is vital to explore the relationshiptd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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China, HBV and MS, to inform prevention and control
strategies.
Methods
Population and study design
This study was conducted with the approval of the Ethical
Review Board in the School of Public Health, Fudan
University and conforms to the principles embodied in
the Declaration of Helsinki.
We evaluated the association between MS and HBV in
a community-based retrospective study founded in 1991
in Shanghai. The cohort was from Putuo district, located
in the northwest of Shanghai, China. Subjects with HBV
were recruited via records from 1991 from the population-
based infectious disease surveillance system. Subjects with
latent HBV infections (defined as asymptomatic, but
positive for HBV surface antigen for more than 6 months)
were classified as “exposed” (Figure 1). After excluding
subjects with MS when they entered into the cohort, sub-
jects who had received antiviral or immunosuppressive
therapy, and subjects without informed consent, 480
subjects were enrolled into the study. All of them were
negative for anti-HCV and other types of hepatitis virus,
except for HBV.
Four hundred ninety-six subjects negative for HBV
surface antigen from the same community were classifiedFigure 1 Selection of subjects during study.as “unexposed”. We excluded subjects positive for HCV
or other types of hepatitis virus, as well as those who had
MS when they entered into the cohort (Figure 1).
For each subject, demographic characteristics, family
history, information about tobacco smoking, alcohol
consumption, physical activity, and diet were collected
using a questionnaire on 31 December 2011, the day the
study was completed. Data from physical examinations
and medical histories were collected at entry into the
study from hospital records.
Subjects were followed until MS (the endpoint) appeared
or until study completion. Time of follow-up (in person-
years) was calculated for each subject as the difference
between the date of entry into the cohort and date of
endpoint or date of the end of the study period, whichever
came first. All subjects were given a physical examination
at the end of the study.
Physical examination variables measured were the
following: waist circumference measured at the midpoint
between the lower border of the rib cage and the iliac
crest; seated blood pressure measured 3 times, 1 min
apart, using a standard mercury sphygmomanometer,
with participants resting for at least 30 minutes before the
measurements were made. Blood samples were collected
by venipuncture in the morning after 12 hours fasting.
Laboratory variables measured from the blood samples
were triglycerides (TG), low-density lipoprotein cholesterol
Table 1 Comparison of baseline characteristics between




Exposed group Unexposed group P-value
(N = 480) (N = 496)
Gender
Male 295 (61.5%) 296 (59.7%) 0.5693
Age (years)
<35 17 (3.5%) 16 (3.2%) 0.3498
35-44 59 (12.3%) 45 (9.1%)
45-54 161 (33.5%) 168 (33.9%)
55-64 165 (34.3%) 192 (38.7%)
≥65 78 (16.4%) 75 (15.1%)
Occupation
Factory worker 110 (22.9%) 80 (16.1%) 0.0274
Light manual worker 298 (59.9%) 337 (67.9%)
Catering staff 72 (17.2%) 79 (16.0%)
Education
Primary school 41 (8.5%) 42 (8.5%) 0.0581
Middle school 358 (74.6%) 399 (80.4%)
College and above 81 (16.9%) 55 (11.1%)
Race
Ethnic Han 471 (98.1%) 487 (98.2%) 0.9440
Others 9 (1.9%) 9 (1.8%)
Marital status
Never married 31 (6.5%) 12 (2.4%) 0.0087
Married 419 (87.3%) 450 (90.7%)
Divorced 30 (6.2%) 34 (6.9%)
Family income
(10,000 RMB)
<1 42 (8.8%) 31 (6.3%) 0.0917
1 - <3 125 (26.0%) 126 (25.4%)
3 - <5 180 (37.5%) 190 (38.3%)
5 - <10 113 (23.5%) 114 (23.0%)
≥10 20 (4.2%) 35 (7.0%)
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hepatitis B serology. Definitions of smoking status for sub-
jects were current smokers (if they were actively smoking)
and previous smokers (if they had quit smoking for the past
6 months). Definitions of passive smoking status for sub-
jects reported their history of passive smoking exposure
longer than 5 years. Definitions of alcohol consumption
status for subjects were current alcohol consumption (if
they were actively drinking regardless of amount) and
previous smokers (if they had quit drinking for the past
6 months). Definitions of high-energy food intake were
subjects who reported that they took fried, smoked,
pickled foods and sweets over 5 times in one week.
Definitions of fresh fruits and vegetables intake were
subjects who reported that they took fruits and fresh
vegetables over 5 times in one week. Physical activity
was divided into 2 levels, none physical activity was defined
as those who exercised less than 1 hour per week.
Definition of metabolic syndrome
MS was diagnosed based on the updated National Choles-
terol Education Program Adult Treatment Panel III cri-
teria [4], requiring the presence of three or more of the
following five criteria: (1) waist circumference >90 cm
in men or >80 cm in women; (2) TG >150 mg/dL; (3)
HDL-C <40 mg/dL in men or <50 mg/dL in women;
(4) blood pressure >130/85 mmHg or current use of
antihypertensive medications; (5) FPG >100 mg/dL or
use of oral anti-diabetic agents or insulin.
As a retrospective cohort study, all necessary data was
tracked and collected in 2012 via database/ medical
record. In this type study, we need a good standard to
determine disease status at present time though the
standard didn’t exist in past, so we selected ATP III as
the definition for metabolic syndrome to evaluate the
association between metabolic syndrome and hepatitis
B infection.
Serum viral markers and biochemistry
Blood samples were tested in the laboratory of the Putuo
District Hospital. TG, LDL-C, HDL-C, TC and FPG were
measured using Shanghai standard laboratory test criteria.
HBsAg was detected using routine standard ELISA.
Statistical analysis
The data were presented as percentages for categorical
variables as well as mean with standard deviations for
continuous variables unless mentioned otherwise. Ap-
propriate comparison tests including Chi-square test
and Student’s t test were used for comparison between
groups for categorical variables and continuous variables,
respectively.
To examine the independent associations between po-
tential risk factors and MS, we conducted survival analysisusing Cox proportional hazards models. The covariates
in our models included factors that might influence
the development of MS. The strength of association
was presented as hazards ratio (HR) with 95% confi-
dence intervals (95% CI) and P-values. Analysis was
performed using the SAS 9.2 statistical package. All
tests were two-sided and p < 0.05 was considered sta-
tistically significant. First we carried out crude HR
calculation for each potential risk factor adjusting for
common confounders such as age, then explored the
association between HBV infection and MS by adjusting
all potential risk factors.
Table 2 Comparison of potential risk factors between
HBV infection exposed group and unexposed group





(N = 480) (N = 496)
Smoking
Yes 184 (38.3%) 170 (34.3%) 0.1873
Passive smoking
Yes 263 (54.8%) 253 (51.0%) 0.2365
Alcohol consumption
Yes 133 (27.7%) 159 (32.1%) 0.1380
High-energy food intake
Yes 192 (40.0%) 214 (43.1%) 0.3189
Fresh fruit and vegetable intake
Yes 254 (52.9%) 267 (53.8%) 0.7748
Physical activity
Yes 57 (11.9%) 68 (13.7%) 0.3912
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Baseline demographic features
Of the 976 subjects recruited for this study, 480 were
classified as exposed (with latent HBV infection), and
496 were classified as unexposed. The 591 male and 385
female subjects had a median age of 55.5 years. Mean
follow-up was 20.8 person-years in the exposed group
and 20.6 person-years in the unexposed group. Table 1
lists characteristics of both cohorts. Gender, age, education,
race, and family income of the two cohorts were similar;
the cohorts differed in occupation and marital status
(Chi-square test, p > 0.05; see Table 1).
Analyses of possible risk factors
Table 2 shows the results of analyses of known risk
factors for MS. There were no differences in the two
groups for these factors (Chi-square test, p > 0.05).
Association of latent HBV infection with metabolic
syndrome
Until the end of the study period, the crude incidence of
MS across the entire study population was 171 out of
976, and the average rate of MS was 85 per 10000Table 3 Event rates and hazards rations for exposed and une
Characteristics Expose
No. (%) of incidence of MS
Mean (SD) duration of follow-up (years)
Crude event rate (No. of events per 10000 person-years)*
Unadjusted hazards ratio (95% CI) †
Adjusted hazards ratio (95% CI) Δ
*(No. of events/total No. of person-years) × 10,000. † Adjusted for age; Δ Adjusted f
food intake; fresh fruit and vegetable intake; physical activity.person-years. The crude incidence of MS was 119.4 in
the exposed group and 50.8 in the unexposed group.
In the unadjusted analyses, the crude age-adjusted
hazard ratio between HBV infection and MS was 2.46
(95% CI: 1.77, 3.41).
To further clarify the association between latent HBV
infection and MS, the potential risk factors of age, gender,
smoking, alcohol consumption, physical activity, and diet
were included in a multivariate Cox hazards ratio model.
HBV infection and MS were still positively associated
(HR, 2.27; 95% CI: 1.52, 3.38), after adjusting for these
potential risks (Table 3).
Discussion
In this retrospective cohort study, we enrolled 976
subjects, including 480 with latent HBV infections and
496 without HBV infections. Using univariate Cox haz-
ards ratio model analysis, we estimated the age-adjusted
hazards ratio between latent HBV infection and MS (HR,
2.46; 95% CI: 1.77, 3.41). Using multivariate Cox hazards
ratio model analysis, we found that a positive association
between latent HBV infection and MS (HR, 2.27; 95% CI:
1.52, 3.38) after adjusting for risk factors of MS (age,
gender, smoking, passive smoking, alcohol consumption,
physical activity, and diet). We concluded that this retro-
spective cohort study shows a positive association between
latent HBV infection and MS in this cohort.
Two cross-sectional studies in Hangzhou and Taiwan
reported decreased risk for MS in subjects with HBV
infection [20,21]. A cross-section study in Hangzhou
showed MS prevalence in subjects with chronic HBV to
be 5.9% and 8.8% in the control group (OR = 0.65, 95%
CI: 0.48, 0.88) [21]. The same result was observed in the
Taiwan Keelung Community-based Integrated Screening
study, MS prevalence in subjects with chronic HBV and
control subjects was 8% and 10.9% respectively (OR =
0.84, 95% CI: 0.76, 0.93) [20]. In these studies, the criteria
for defining MS were different from those of this study,
and the prevalence of MS in HBV infected subjects may
have been underestimated. Moreover, some potential con-
founders such as BMI and smoking were not adequately
adjusted for. These studies were also limited by sample
size and representation. The largest and latest study whichxposed groups
d group (HBV infection) Unexposed group (No HBV infection)
119 (24.8) 52 (10.5)
20.8 (2.0) 20.6 (2.4)
119.4 50.8
2.46 (1.77 to 3.41) 1.00
2.27 (1.52 to 3.38) 1.00
or age; gender; smoking; passive smoking; alcohol consumption; high-energy
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NHANES III in US also reported an inverse relationship
between chronic hepatitis B infection and MS [26]. This
study was cross-section study design it included subjects
from 2 months to elder. Two independent cross-section
studies from Taiwan [27] and Slovakia [28] showed
that there was no association between HBV and MS, in
Taiwan’s study no individual components of MS was
associated with HBV infection but opposite result
found in Slovakia’s study that HBV infection may de-
crease level of TC and LDL. In other cross-section study
from Taiwan showed that compared with healthy person,
patients with chronic HBV infection had lower level of
TG and LDL [29]. However these cross-section studies
cannot examine the temporal association. In contrast, we
used a retrospective cohort study based on a community
population, and subjects with latent HBV infection received
no antiviral therapy. Over an almost 20-year follow-up
period, adjusted for some possible confounders, we evalu-
ated the association between HBV infection and MS.
Similarly, Yen et al. [30] found that, compared to subjects
with serum protective titers from hepatitis B vaccination,
those with natural HBV infection had 58% higher risk for
MS after adjusting for age, gender, BMI, smoking and
other possible confounders. A previous study indicated
that insulin resistance with excessive flux of fatty acids is
implicated as a possible mechanisms of MS [31]. There is
a large body of evidence supporting a possible connection
between HCV infection and MS through insulin resist-
ance [15,32-34]. It is still unknown if there is a similar
mechanism between HBV infection and MS. Further bio-
logical, molecular and genetic studies are needed to test
this hypothesis.
A dramatic decline of HBV infection in Chinese children
began more than two decades ago, due to an effective
hepatitis B vaccination program [35]. Nevertheless, HBV
infection is still a severe health threat to adults over
40 years old without regular hepatitis B vaccination, with
the prevalence of HBV infection at nearly 10% [9]. MS has
become one of the major public health challenges in
China; the prevalence according to modified ATP III cri-
teria in adult men was 28.4% and 35.1% in adult women,
in a community-based survey in Shanghai [36]. Our study
indicates that latent HBV infection is a risk factor for MS
development. Thus, in planning the prevention and control
strategy for MS, more attention must be given to address-
ing the needs of the population with ‘silent’ HBV.
Our study has several potential limitations. First, our
study is observational, and although the baseline differ-
ences between our cohorts were minor, we may not have
been able to adjust adequately for such differences. Import-
ant confounders may also have been unrecognized. Second,
the detection methods, reference ranges and detection re-
agents for HBV infection varied over the 20-year period ofthe study. Third, we reviewed all recorded all medical his-
tory of subjects to define the endpoint of MS. We assumed
that MS in this population would be represented in hos-
pital records, even if all cases did not meet the same lab
criteria. Fourth, given the limitations of our data, we could
not adjust for all known important factors affecting the risk
of MS, such as diet, presence and severity of hypertension,
and lipid status. Fifth, inconsistent with other studies
[37-39], we did not find associations between lifestyle fac-
tors such as smoking, alcohol consumption, high-energy
food intake, fresh fruit and vegetable intake, physical activ-
ity and MS in this study. This is doubtless because of the
difficulties in obtaining this type of detailed information for
a retrospective study.
Conclusions
Our study shows that latent HBV infection is associated
with an increased prevalence of MS. It is critical that the
medical establishment give more attention to those over
40 with have latent HBV infections, as they have increased
risk for developing MS and will increase the chronic
disease burden in China.
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